Positron emission tomography employs radiotracers most commonly 18F-FDG for glucose metabolism, or amyloid and tau specific ligands to visualize molecular hallmarks of Alzheimer’s disease in vivo [21]. This evidence concerns the gene MAPT and Alzheimer disease.